These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15170500)

  • 21. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
    Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
    Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients.
    Mitome J; Yamamoto H; Saito M; Yokoyama K; Marumo K; Hosoya T
    Calcif Tissue Int; 2011 Jun; 88(6):521-9. PubMed ID: 21499867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
    Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
    Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine.
    Edelstein D; Brownlee M
    Diabetes; 1992 Jan; 41(1):26-9. PubMed ID: 1727735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats.
    Waanders F; Greven WL; Baynes JW; Thorpe SR; Kramer AB; Nagai R; Sakata N; van Goor H; Navis G
    Nephrol Dial Transplant; 2005 Oct; 20(10):2060-70. PubMed ID: 15956058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites.
    Cervantes-Laurean D; Schramm DD; Jacobson EL; Halaweish I; Bruckner GG; Boissonneault GA
    J Nutr Biochem; 2006 Aug; 17(8):531-40. PubMed ID: 16443355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons.
    Horie K; Miyata T; Yasuda T; Takeda A; Yasuda Y; Maeda K; Sobue G; Kurokawa K
    Biochem Biophys Res Commun; 1997 Jul; 236(2):327-32. PubMed ID: 9240434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modification of vimentin: a general mechanism of nonenzymatic glycation in human skin.
    Kueper T; Grune T; Muhr GM; Lenz H; Wittern KP; Wenck H; Stäb F; Blatt T
    Ann N Y Acad Sci; 2008 Apr; 1126():328-32. PubMed ID: 18448838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonyl stress and long-term uremic complications.
    Miyata T; Kurokawa K; van Ypersele de Strihou C
    Adv Nephrol Necker Hosp; 1998; 28():311-9. PubMed ID: 9889996
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal.
    Nagaraj RH; Sarkar P; Mally A; Biemel KM; Lederer MO; Padayatti PS
    Arch Biochem Biophys; 2002 Jun; 402(1):110-9. PubMed ID: 12051689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone.
    Ashraf JM; Ahmad S; Rabbani G; Jan AT; Lee EJ; Khan RH; Choi I
    IUBMB Life; 2014 Oct; 66(10):686-93. PubMed ID: 25380060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced levels of non-enzymatic glycation and pentosidine crosslinking in spontaneous osteoarthritis progression.
    Willett TL; Kandel R; De Croos JN; Avery NC; Grynpas MD
    Osteoarthritis Cartilage; 2012 Jul; 20(7):736-44. PubMed ID: 22469851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical properties and collagen cross-linking of the patellar tendon in old and young men.
    Couppé C; Hansen P; Kongsgaard M; Kovanen V; Suetta C; Aagaard P; Kjaer M; Magnusson SP
    J Appl Physiol (1985); 2009 Sep; 107(3):880-6. PubMed ID: 19556458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Collagen in its fibrillar state is protected from glycation.
    Slatter DA; Avery NC; Bailey AJ
    Int J Biochem Cell Biol; 2008; 40(10):2253-63. PubMed ID: 18436470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced glycoxidation end products in patients with multiple sclerosis.
    Kalousová M; Havrdová E; Mrázová K; Spacek P; Braun M; Uhrová J; Germanová A; Zima T
    Prague Med Rep; 2005; 106(2):167-74. PubMed ID: 16315765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In end stage osteoarthritis, cartilage tissue pentosidine levels are inversely related to parameters of cartilage damage.
    Vos PA; Mastbergen SC; Huisman AM; de Boer TN; DeGroot J; Polak AA; Lafeber FP
    Osteoarthritis Cartilage; 2012 Mar; 20(3):233-40. PubMed ID: 22227209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes.
    Sugiyama T; Okuno T; Fukuhara M; Oku H; Ikeda T; Obayashi H; Ohta M; Fukui M; Hasegawa G; Nakamura N
    Exp Eye Res; 2007 Sep; 85(3):406-12. PubMed ID: 17678894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.